Your browser doesn't support javascript.
loading
Self-assembly nanovaccine containing TLR7/8 agonist and STAT3 inhibitor enhances tumor immunotherapy by augmenting tumor-specific immune response.
Zhang, Lele; Huang, Jiacheng; Chen, Xiaona; Pan, Caixu; He, Yong; Su, Rong; Guo, Danjing; Yin, Shengyong; Wang, Shuai; Zhou, Lin; Chen, Jianxiang; Zheng, Shusen; Qiao, Yiting.
Afiliação
  • Zhang L; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Huang J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
  • Chen X; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Pan C; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
  • He Y; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Su R; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
  • Guo D; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Yin S; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
  • Wang S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Zhou L; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Chen J; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
  • Zheng S; Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
  • Qiao Y; NHC Key Laboratory of Combined Multi-organ Transplantation, Hangzhou, People's Republic of China.
J Immunother Cancer ; 9(8)2021 08.
Article em En | MEDLINE | ID: mdl-34452929
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Fator de Transcrição STAT3 / Receptor 7 Toll-Like / Receptor 8 Toll-Like / Nanopartículas / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas Anticâncer / Fator de Transcrição STAT3 / Receptor 7 Toll-Like / Receptor 8 Toll-Like / Nanopartículas / Imunoterapia Tipo de estudo: Prognostic_studies Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2021 Tipo de documento: Article